Data search
Results for MligTC455_52282
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_52282 | 211 | 4.39 | Mlig455_015194 | Neo: - Age: Down-Down-Up |
MCTS1 | Mlig455_015194 {REF} {Length: 1784} {TRANSSPLICED} {Pfam: Pre-PUA-like domain [PF17832.3, score=80.1]; PUA domain [PF01472.22, score=62.0]} {Human: ENSG00000232119, MCTS1, MCTS1, re-initiation and release factor, [RH, Score=240, Expect=2e-81]; ENSG00000101898, MCTS2P, malignant T cell amplified sequence 2, pseudogene, [RH, Score=228, Expect=7e-77]} {Mouse: ENSMUSG00000000355, Mcts1, malignant T cell amplified sequence 1, [RH, Score=241, Expect=6e-82]; ENSMUSG00000042814, Mcts2, malignant T cell amplified sequence 2, [RH, Score=230, Expect=1e-77]} {Dmel: FBgn0029833, MCTS1, Malignant T cell amplified sequence 1, [RH, Score=229, Expect=2e-77]} {Celegans: WBGene00015703, C11D2.7, [RH, Score=225, Expect=6e-76]} {Smed: dd_Smed_v6_3656_0_1, dd_Smed_v6_3656_0_1, [RH, Score=262, Expect=1e-90]} {RNA1509_10311, RNA1509_33036} {RNA1310_28656, RNA1509_33036} {RNA1509_33036, RNA815_13050} |
Cumulative graph for MligTC455_52282
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | 0.942 | 2.757 | 0.67592 | 1.00000 | |
| RegionR2 | -0.136 | 2.757 | 0.85462 | 1.00000 | |
| RegionR3 | 1.272 | 2.757 | 0.15733 | 0.67120 | |
| RegionR4 | 2.272 | 2.757 | 0.02742 | 0.12743 | |
| RegionR5 | 0.775 | 2.757 | 0.36913 | 0.72180 | |
| RegionR6 | 0.527 | 2.757 | 0.53651 | 1.00000 | |
| RegionR7 | -0.065 | 2.757 | 0.83951 | 1.00000 | |
| RegionR8 | -5.585 | 2.757 | 0.07065 | 0.50935 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 1.879 | 2.757 | 0.46918 | 1.00000 | |
| RegenerationR2 | -0.534 | 2.757 | 0.51696 | 0.87846 | |
| RegenerationR3 | 0.17 | 2.757 | 0.84351 | 0.99582 | |
| RegenerationR4 | 0.236 | 2.757 | 0.78345 | 0.98207 | |
| RegenerationR5 | 0.688 | 2.757 | 0.39148 | 0.79327 | |
| RegenerationR6 | -0.212 | 2.757 | 0.81542 | 0.98468 | |
| RegenerationBL | 2.205 | 2.757 | 0.16112 | 0.48146 | |
| RegenerationTP | 3.106 | 2.757 | 0.12054 | 0.52965 |
Genes with expression patterns similar to MligTC455_52282
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_52282 | 211 | 4.39 | Mlig455_015194 | Neo: - Age: Down-Down-Up |
MCTS1 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_015194 {REF} {Length: 1784} {TRANSSPLICED} {Pfam: Pre-PUA-like domain [PF17832.3, score=80.1]; PUA domain [PF01472.22, score=62.0]} {Human: ENSG00000232119, MCTS1, MCTS1, re-initiation and release factor, [RH, Score=240, Expect=2e-81]; ENSG00000101898, MCTS2P, malignant T cell amplified sequence 2, pseudogene, [RH, Score=228, Expect=7e-77]} {Mouse: ENSMUSG00000000355, Mcts1, malignant T cell amplified sequence 1, [RH, Score=241, Expect=6e-82]; ENSMUSG00000042814, Mcts2, malignant T cell amplified sequence 2, [RH, Score=230, Expect=1e-77]} {Dmel: FBgn0029833, MCTS1, Malignant T cell amplified sequence 1, [RH, Score=229, Expect=2e-77]} {Celegans: WBGene00015703, C11D2.7, [RH, Score=225, Expect=6e-76]} {Smed: dd_Smed_v6_3656_0_1, dd_Smed_v6_3656_0_1, [RH, Score=262, Expect=1e-90]} {RNA1509_10311, RNA1509_33036} {RNA1310_28656, RNA1509_33036} {RNA1509_33036, RNA815_13050} |
| 2. | MligTC455_52284 | 178 | 3.71 | Mlig455_027155 | Neo: - Age: - |
MCTS1 | 4.447 | 0.958 | 0.886 | - | 0.835 | 0.884 | 0.884 | Mlig455_027155 {REF} {Length: 1842} {TRANSSPLICED} {Pfam: Pre-PUA-like domain [PF17832.3, score=80.5]; PUA domain [PF01472.22, score=62.0]} {Human: ENSG00000232119, MCTS1, MCTS1, re-initiation and release factor, [RH, Score=238, Expect=8e-81]; ENSG00000101898, MCTS2P, malignant T cell amplified sequence 2, pseudogene, [RH, Score=230, Expect=2e-77]} {Mouse: ENSMUSG00000000355, Mcts1, malignant T cell amplified sequence 1, [RH, Score=239, Expect=3e-81]; ENSMUSG00000042814, Mcts2, malignant T cell amplified sequence 2, [RH, Score=231, Expect=4e-78]} {Dmel: FBgn0029833, MCTS1, Malignant T cell amplified sequence 1, [RH, Score=230, Expect=7e-78]} {Celegans: WBGene00015703, C11D2.7, [RH, Score=225, Expect=9e-76]} {Smed: dd_Smed_v6_3656_0_1, dd_Smed_v6_3656_0_1, [RH, Score=261, Expect=5e-90]} {RNA1509_10311, RNA1509_8184} {RNA1310_28656, RNA1509_10311, RNA1509_8184} {RNA1509_10311, RNA1509_8184, RNA815_13050} |
| 3. | MligTC455_30043 | 144 | 3 | Mlig455_067016 | Neo: - Age: Up-Down-Up |
TMEM94 | 2.379 | - | - | 0.700 | 0.724 | - | 0.955 | Mlig455_067016 {REF} {Length: 5329} {Human: ENSG00000177728, TMEM94, transmembrane protein 94, [RH, Score=206, Expect=6e-53]} {Mouse: ENSMUSG00000020747, Tmem94, transmembrane protein 94, [RH, Score=205, Expect=6e-53]} {Dmel: FBgn0022153, l(2)k05819, lethal (2) k05819, [RH, Score=400, Expect=5e-117]} {Celegans: WBGene00017010, D1007.15, [RH, Score=189, Expect=2e-48]} {Smed: dd_Smed_v6_12358_0_1, dd_Smed_v6_12358_0_1, [RH, Score=325, Expect=5e-93]} {RNA1509_7674} {RNA1310_1886.2} {RNA815_651} |
| 4. | MligTC455_19452 | 506 | 10.55 | Mlig455_021415 | Neo: - Age: Down-Up-Down |
CLPTM1L | 0.978 | - | - | - | - | - | 0.978 | Mlig455_021415 {REF} {Length: 3183} {TRANSSPLICED} {Pfam: Cleft lip and palate transmembrane protein 1 (CLPTM1) [PF05602.14, score=307.0]} {Human: ENSG00000274811, CLPTM1L, CLPTM1 like, [RH, Score=448, Expect=2e-152]; ENSG00000049656, CLPTM1L, CLPTM1 like, [RH, Score=448, Expect=2e-152]} {Mouse: ENSMUSG00000021610, Clptm1l, CLPTM1-like, [RH, Score=458, Expect=2e-156]} {Dmel: FBgn0030456, CG4332, [RH, Score=418, Expect=1e-140]} {Celegans: WBGene00011761, T13H5.8, [RH, Score=407, Expect=2e-136]} {Smed: dd_Smed_v6_2192_0_1, dd_Smed_v6_2192_0_1, [RH, Score=447, Expect=4e-153]} {RNA1509_42391} {RNA1310_12720.1} {RNA815_4561} |
Berezikov Lab - 2020-2021 © ERIBA